13
POPS"Mad, Bad and Sad"
If male doctors conspired to define madness, responding to behaviors that flouted the social conventions of their culture, female patients, in the attempt to understand themselves and their context, and maybe even to create or bolster identity, colluded with those same doctors to satisfy the changing definitions of madness. “Often enough,” Appignanesi notes, “extreme expressions of the culture’s malaise, symptoms and disorders mirrored the time’s order.” While “Mad, Bad and Sad” echoes and enlarges upon Elaine Showalter’s book “The Female Malady: Women, Madness, and English Culture, 1830-1980,” Showalter’s perspective is more exclusively feminist, arguing that psychiatry as practiced on women is a history of their subjugation and control by men. But as Appignanesi makes clear, women have had no little role in creating and fulfilling the definitions of their madness.<< "Mad, Bad and Sad: A History of Women and the Mind Doctors from 1800 to the Present" by Lisa Appignanesi.
6
POPSMyths of Mental Illness: chemicals or people? Comfortably Numb: How Psychiatry Is Medicating a Nation by Charles Barber Excellent interview with author, difficult to do justice in clip. Part of the growing critique of the myth that mental distress is solely a matter of chemical imbalance, 'hardwiring', genetics etc. Relocates the human in culture and ideology rather than identifying a biological misfunctioning atom.
13
POPSShyness Gene Teased Out If further research links RGS2 variations to anxiety disorders, the gene may make a good treatment target, Smoller's team writes in the Archives of General Psychiatry.<<
16
POPSWho Are We? Coming of Age on Antidepressants The reason has to do with the way drugs are tested and approved. To get F.D.A. approval, a drug has to beat a placebo in two randomized clinical trials that typically involve a few hundred subjects who are treated for relatively short periods, usually 4 to 12 weeks.So drugs are approved based on short-term studies for what turns out to be long-term — often lifelong — use in the world of clinical practice. What do I say to a depressed patient who is doing well after five years on such a drug but can’t stop without a depressive relapse and who wants reassurance that the drug has no long-term adverse effects?I usually say that we have no evidence that the drug poses a risk with long-term use; and since the risk of untreated depression is much greater than the hypothetical risk of the drug, it makes sense to stay on it.
4
POPSToxic Psychiatry Useful website for work of psychiatrist Dr Breggin. Up to date. WARNING! When trying to withdraw from many psychiatric drugs, patients can develop serious and even life-threatening emotional and physical reactions. In short, it is dangerous not only to start taking psychiatric drugs but also can be hazardous to stop taking them. Therefore, withdrawal from psychiatric drugs should be done under clinical supervision. Principles of psychiatric medication withdrawal are discussed in Dr. Peter Breggin's book, Brain Disabling Treatments in Psychiatry: Drugs, Electroshock and the Psychopharaceutical Complex (Springer, NY, 2008).
5
POPSParanoid Professor Peter Kinderman, a Liverpool University psychologist and member of the British Psychological Society, said: "This is a valuable and useful tool. "It helps us to understand more about paranoia and I can see it could have a role to play in assessment and therapy."
26
POPSDepression can be Good for You There is serious depression that needs help. There are poverty, abuse, bad circumstance that need addressing. But for most of us, a bit of depression, the article suggests, is a catalyst for refelction, change and growth
Newest Clips
see Newest Clips
5
Latest Pops
Latest Comments
Most Pops
Tags
Print
Save
Turn on live update